Title Image

Corporate Governance

Board of Directors

Handa upholds principles of integrity, emphasizes shareholder rights and principles, and firmly believes that a transparent and efficient board of directors is the cornerstone of corporate sustainability.

The board of directors of All Handa Pharmaceuticals, Inc. is composed of nine directors with professional backgrounds and experience. The task of the board of directors is to enhance the Company’s long-term corporate value and improve corporate governance to protect the interests of stakeholders. The board also provides strategic management assistance and ensures the Company adopts and implements planned processes to achieve high standards of integrity, fairness and ethical values.

As a result, three of the nine board members are independent directors and a candidate nomination system has been adopted. The board selects suitable candidates from the list of nominees. An Audit Committee and Remuneration Committee directly subordinate to the board have been established. These two functional committees assist the board in the performance of its duties in accordance with their authorities.

Board Members

Chairman

Bill Liu Ph.D.

Nationality:USA | Date elected:2025.06.17

● Academic background

Ph.D of Industrial and Physical Pharmacy, Purdue University

● Professional experience

COO and Vice President, Anchen Pharmaceuticals, Inc.
Manager, Business Development and Licensing, Yamanouchi Pharma Technologies
Group Leader, Formulation Development, Impax Pharmaceuticals, Inc.

Director

Maggie Chang Ph.D.

Nationality:USA | Date elected:2025.06.17

● Academic background

Ph.D of Industrial and Physical Pharmacy, Purdue University

● Professional experience

Vice President of Quality Affairs, Anchen Pharmaceuticals, Inc.
Group Leader Analytical Service, Impax Pharmaceuticals, Inc.

Director

Toshiyo Chen

Nationality:ROC | Date elected:2025.06.17

● Academic background

EMBA, National Taiwan University
Bachelor of Pharmacy, Kaohsiung Medical University

● Professional experience

General Manager, TSH Biopharm Corporation Ltd.
Chairman, Pharmira Laboratory Company Ltd.
Sales Director/Senior Director, TTY Biopharm Company Limited.

Director

Willie Lin Ph.D.

Nationality:ROC | Date elected:2025.06.17

● Academic background

Postdoctoral Researcher of Plant Pathology and Microbology, University of California, Berkeley
Ph.D of Biological Chemistry, Kansas State University

● Professional experience

Chairman/General Manage, Microbio Co., Ltd.
Chairman/General Manage, Fountain Biopharma
General Manage/COO, Fountain Biopharma
Assistant Vice President, China Chemical & Pharmaceutical Co., Ltd.

Director

Susan Lu

Nationality:ROC | Date elected:2025.06.17

● Academic background

Master of Finance, National Sun Yat-sen University
Bachelor of Agricultural Economics, National Taiwan University

● Professional experience

General Manager, ScinoPharm Taiwan, Ltd.
Director, President Securities Corporation
Director, President Transnet Corp.

Director

Jo Shen Ph.D.

Nationality:ROC | Date elected:2025.06.17

● Academic background

Ph.D. of Chemistry, Lehigh University
M.S. of Chemistry, University of Iowa
Bachelor of Chemical Engineering, National Taiwan University

● Professional experience

Venture Partner, Vivo Capital
Co-Founder, Former President & CEO, ScinoPharm
Sr. Board of Director of Taiwan Bio-Industry Organization
Independent Board Member of Lumosa
Advisor of National Health Research Institute

Independent Director

Jinn Wu Ph.D.

Nationality:USA | Date elected:2025.06.17

● Academic background

Ph.D of Pharmacy, Ohio State University
Master of Pharmacy, National Taiwan University

● Professional experience

President and Chief Executive Officer, XenoBiotic Laboratories, Inc.
CEO, Nanjing XenoBioticLaboratories, Inc.
Chief Scientific Officer Strategic Advisor, WuXi AppTec
Director, Kinex Pharmaceuticals, Inc.

Independent Director

James Hsu

Nationality:ROC | Date elected:2025.06.17

● Academic background

Master of Accounting, University of Missouri, Columbia, USA
Bachelor of Industrial Engineering, National Tsing Hua University

● Professional experience

General Manager, CDIB Biotech Venture Management, Inc.
Director and General Manager, CDIB Capital Healthcare Ventures II, L.P.
Senior Vice President, China Development Industrial Bank
Deputy General Manager, CTBC Venture Capital Co., Ltd.

Independent Director

Patricia Chou

Nationality:ROC | Date elected:2025.06.17

● Academic background

MBA, Haas School of Business, University of California, Berkeley, USA
Master of Accounting, University of Southern California, USA
Bachelor of Accounting, National Taiwan University

● Professional experience

CFO/Spokesperson, Diamond Biofund Inc.
CFO, Lite-On Technology Corporation
CFO/Executive Director, ASM Pacific Technology Limited
CFO/Spokesperson, Foresee Pharmaceuticals Co., Ltd.
CFO/Spokesperson, ScinoPharm Taiwan, Ltd.

Board Diversity Policy and 2025 Implementation Overview:

  1. The Company targets a minimum of three independent directors and at least one-fifth of the total board seats to be held by independent directors. As of now, the Board comprises nine members, of whom three are independent directors.
  2. The Company aims to have each gender represented by at least one-third of the total board seats. Currently, four out of nine directors are female, achieving this objective.
  3. The Company seeks to ensure that Board members possess a broad range of professional backgrounds, including expertise in finance or accounting, legal affairs, business management, and industry-specific knowledge. The current composition of the Board reflects a well-balanced mix of the required professional qualifications.

Criterion

Name

Operational judgment abilities Accounting and financial analysis abilities Management and administration abilities Industry knowledge International market perspective Leadership skills Decision-making skills Risk management skills
Bill Liu V V V V V V V
Maggie Chang V V V V V
Toshiyo Chen V V V V V V V
Willie Lin V V V V V V V
Susan Lu V V V V V V
Jo Shen V V V V V V
Jinn Wu V V V V V V V
James Hsu V V V V V V V
Patricia Chou V V V V V V